作者
Tullia Todros, P Verdiglione, G Oggè, Dario Paladini, P Vergani, Simona Cardaropoli
发表日期
2006/3
期刊
British journal of clinical pharmacology
卷号
61
期号
3
页码范围
336-340
出版商
Blackwell Publishing Ltd
简介
Aims
Toxoplasma infection in pregnancy is usually treated with long‐term administration of the macrolide spiramycin to prevent fetal malformations. We had empirically observed that treated patients seldom developed pregnancy‐induced hypertension (PIH), a common and severe disorder of pregnancy whose aetiology and pathogenesis are still debated. Some clinical and experimental data suggest that infection could play a role in its development.
Methods
To test this hypothesis, we studied a cohort of 417 pregnant women treated with spiramycin because of seroconversion for Toxoplasma gondii and 353 low‐risk women who did not take any antibiotic during pregnancy. PIH was defined as blood pressure >140/90 mmHg on two or more occasions, occurring after 20 weeks of gestational age.
Results
Seventeen (5.2%) women in the control group developed PIH compared with two (0.5%) in the case group …
引用总数
2006200720082009201020112012201320142015201620172018201920202021202220232024114123222442313231
学术搜索中的文章
T Todros, P Verdiglione, G Oggè, D Paladini, P Vergani… - British journal of clinical pharmacology, 2006